Exosomes carrying the CD20 receptor on the lipid membrane derived from B-cell lymphoma can bind to the anti-CD20 antibody rituximab, thereby mediating its extracellular depletion [81]. This evidence concerns the gene MS4A1 and B-cell non-Hodgkin lymphoma.